Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on May 18, 2025
Pomerantz Law Firm Announces the Filing of a Class Action Against MicroStrategy Incorporated d/b/a Strategy and Certain Officers – MSTR
GlobeNewswire
·
May 18, 2025
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers. The class action, filed in …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Fortress Energy Inc. - NFE
GlobeNewswire
·
May 18, 2025
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Digimarc Corporation of Class Action Lawsuit and Upcoming Deadline - DMRC
GlobeNewswire
·
May 18, 2025
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC). Such investors are advised to contact Danielle Peyton at newaction@ …
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
ZYXI Investors Have the Opportunity to Lead the Zynex Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
PPTA Investors Have the Opportunity to Lead the Perpetua Resources Corp. Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Krispy Kreme
GlobeNewswire
·
May 18, 2025
Faruqi …
CAR Investors Have the Opportunity to Lead the Avis Budget Group Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
NSSC Investors Have the Opportunity to Lead the Napco Security Technologies Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
GlobeNewswire
·
May 18, 2025
Faruqi …
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
GlobeNewswire
·
May 18, 2025
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR Analyses of Real-World Data Reveal Disparities in Outcomes In Females and Older Patients with Non- …
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 18, 2025
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting
GlobeNewswire
·
May 18, 2025
Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …
Best Anti-Snoring Device 2025: AirSnore Mouthpiece & Drops Review for Sleep Apnea & Deprivation Relief
GlobeNewswire
·
May 18, 2025
Glasgow, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction Consistent, uninterrupted sleep is critical to maintaining sharp focus, stable mood, and long-term health. Yet millions of adults struggle with nightly snoring or mild obstructive sleep apnea — often …
Best Credit Repair & Score Boost 2025: The Credit People Review For Fast Credit Fix & Financial Improvement
GlobeNewswire
·
May 18, 2025
Salt Lake City, Utah, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Credit Score Woes in 2025 …